-
Je něco špatně v tomto záznamu ?
Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study
E. Laukhtina, A. Boehm, B. Peyronnet, CA. Bravi, J. Batista Da Costa, F. Soria, D. D'Andrea, P. Rajwa, F. Quhal, T. Yanagisawa, F. König, H. Mostafaei, D. Enikeev, A. Ingels, G. Verhoest, F. D'Hondt, A. Mottrie, S. Joniau, H. Van Poppel, A. de la...
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, multicentrická studie
NLK
ProQuest Central
od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-02-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-02-01 do Před 1 rokem
- MeSH
- cystektomie MeSH
- karcinom z přechodných buněk * patologie chirurgie MeSH
- lidé MeSH
- močový měchýř chirurgie MeSH
- nádory močové trubice * patologie chirurgie MeSH
- nádory močového měchýře * patologie chirurgie MeSH
- retrospektivní studie MeSH
- uretra patologie chirurgie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
INTRODUCTION: The optimal management of the urethra in patients planned for radical cystectomy (RC) remains unclear. We sought to evaluate the impact of urethrectomy on perioperative and oncological outcomes in patients treated with RC for non-metastatic urothelial carcinoma of the bladder (UCB). MATERIALS AND METHODS: We assessed the retrospective data from patients treated with RC for UCB of five European University Hospitals. Associations of urethrectomy with progression-free (PFS), cancer-free (CSS), and overall (OS) survivals were assessed in univariable and multivariable Cox regression models. We performed a subgroup analysis in patients at high risk for urethral recurrence (UR) (urethral invasion and/or bladder neck invasion and/or multifocality and/or prostatic urethra involvement). RESULTS: A total of 887 non-metastatic UCB patients were included. Among them, 146 patients underwent urethrectomy at the time of RC. Urethrectomy was performed more often in patients with urethral invasion, T3/4 tumor stage, CIS, positive frozen section analysis of the urethra, and those who received neoadjuvant chemotherapy, underwent robotic RC, and/or received an ileal conduit urinary diversion (all p < 0.001). Estimated blood loss and the postoperative complication rate were comparable between patients who received an urethrectomy and those who did not. Urethrectomy during RC was not associated with PFS (HR 0.83, p = 0.17), CSS (HR 0.93, p = 0.67), or OS (HR 1.08, p = 0.58). In the subgroup of 276 patients at high risk for UR, urethrectomy at the time of RC decreased the risk of progression (HR 0.58, p = 0.04). CONCLUSION: In our study, urethrectomy at the time of RC seems to benefit only patients at high risk for UR. Adequate risk assessment of UCB patients' history may allow for better clinical decision-making and patient counseling.
Department of Urology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Urology King Fahad Specialist Hospital Dammam Saudi Arabia
Department of Urology La Croix Du Sud Hospital Quint Fonsegrives France
Department of Urology Medical University of Silesia Zabrze Poland
Department of Urology Onze Lieve Vrouwziekenhuis Hospital Aalst Belgium
Department of Urology The Jikei University School of Medicine Tokyo Japan
Department of Urology University Hospital of Rennes Rennes France
Department of Urology University Hospital of Tours Tours France
Department of Urology University Hospitals Leuven Leuven Belgium
Department of Urology University Medical Centre Hamburg Eppendorf Hamburg Germany
Department of Urology University of Texas Southwestern Dallas TX USA
Department of Urology Weill Cornell Medical College New York NY USA
Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman Jordan
Institute for Urology and Reproductive Health Sechenov University Moscow Russia
Karl Landsteiner Institute of Urology and Andrology Vienna Austria
Research Center for Evidence Based Medicine Tabriz University of Medical Sciences Tabriz Iran
Unit of Urology Division of Oncology URI IRCCS Ospedale San Raffaele Milan Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017935
- 003
- CZ-PrNML
- 005
- 20220804134454.0
- 007
- ta
- 008
- 220720s2022 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00345-022-04025-z $2 doi
- 035 __
- $a (PubMed)35596017
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Laukhtina, Ekaterina $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia $1 https://orcid.org/0000000289530272
- 245 10
- $a Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study / $c E. Laukhtina, A. Boehm, B. Peyronnet, CA. Bravi, J. Batista Da Costa, F. Soria, D. D'Andrea, P. Rajwa, F. Quhal, T. Yanagisawa, F. König, H. Mostafaei, D. Enikeev, A. Ingels, G. Verhoest, F. D'Hondt, A. Mottrie, S. Joniau, H. Van Poppel, A. de la Taille, K. Bensalah, F. Bruyère, SF. Shariat, B. Pradere
- 520 9_
- $a INTRODUCTION: The optimal management of the urethra in patients planned for radical cystectomy (RC) remains unclear. We sought to evaluate the impact of urethrectomy on perioperative and oncological outcomes in patients treated with RC for non-metastatic urothelial carcinoma of the bladder (UCB). MATERIALS AND METHODS: We assessed the retrospective data from patients treated with RC for UCB of five European University Hospitals. Associations of urethrectomy with progression-free (PFS), cancer-free (CSS), and overall (OS) survivals were assessed in univariable and multivariable Cox regression models. We performed a subgroup analysis in patients at high risk for urethral recurrence (UR) (urethral invasion and/or bladder neck invasion and/or multifocality and/or prostatic urethra involvement). RESULTS: A total of 887 non-metastatic UCB patients were included. Among them, 146 patients underwent urethrectomy at the time of RC. Urethrectomy was performed more often in patients with urethral invasion, T3/4 tumor stage, CIS, positive frozen section analysis of the urethra, and those who received neoadjuvant chemotherapy, underwent robotic RC, and/or received an ileal conduit urinary diversion (all p < 0.001). Estimated blood loss and the postoperative complication rate were comparable between patients who received an urethrectomy and those who did not. Urethrectomy during RC was not associated with PFS (HR 0.83, p = 0.17), CSS (HR 0.93, p = 0.67), or OS (HR 1.08, p = 0.58). In the subgroup of 276 patients at high risk for UR, urethrectomy at the time of RC decreased the risk of progression (HR 0.58, p = 0.04). CONCLUSION: In our study, urethrectomy at the time of RC seems to benefit only patients at high risk for UR. Adequate risk assessment of UCB patients' history may allow for better clinical decision-making and patient counseling.
- 650 12
- $a karcinom z přechodných buněk $x patologie $x chirurgie $7 D002295
- 650 _2
- $a cystektomie $7 D015653
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a uretra $x patologie $x chirurgie $7 D014521
- 650 12
- $a nádory močové trubice $x patologie $x chirurgie $7 D014523
- 650 _2
- $a močový měchýř $x chirurgie $7 D001743
- 650 12
- $a nádory močového měchýře $x patologie $x chirurgie $7 D001749
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Boehm, Axelle $u Department of Urology, University Hospital of Tours, Tours, France
- 700 1_
- $a Peyronnet, Benoit $u Department of Urology, University Hospital of Rennes, Rennes, France
- 700 1_
- $a Bravi, Carlo Andrea $u Unit of Urology, Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy $u Department of Urology, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium $u ORSI Academy, Melle, Belgium
- 700 1_
- $a Batista Da Costa, Jose $u Department of Urology, University Hospital Henri Mondor, AP-HP, UPEC, AP-HP, 51 Avenue du Maréchal de Lattre de Tassigny, 95010, Créteil Cedex, France
- 700 1_
- $a Soria, Francesco $u Division of Urology, Department of Surgical Sciences, AOU Città della Salute e della Scienza di Torino, Torino School of Medicine, Turin, Italy
- 700 1_
- $a D'Andrea, David $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria
- 700 1_
- $a Rajwa, Pawel $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria $u Department of Urology, Medical University of Silesia, Zabrze, Poland
- 700 1_
- $a Quhal, Fahad $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria $u Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia
- 700 1_
- $a Yanagisawa, Takafumi $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria $u Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
- 700 1_
- $a König, Frederik $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria $u Department of Urology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
- 700 1_
- $a Mostafaei, Hadi $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria $u Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
- 700 1_
- $a Enikeev, Dmitry $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
- 700 1_
- $a Ingels, Alexandre $u Department of Urology, University Hospital Henri Mondor, AP-HP, UPEC, AP-HP, 51 Avenue du Maréchal de Lattre de Tassigny, 95010, Créteil Cedex, France
- 700 1_
- $a Verhoest, Gregory $u Department of Urology, University Hospital of Rennes, Rennes, France
- 700 1_
- $a D'Hondt, Frederiek $u Department of Urology, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium $u ORSI Academy, Melle, Belgium
- 700 1_
- $a Mottrie, Alexandre $u Department of Urology, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium $u ORSI Academy, Melle, Belgium
- 700 1_
- $a Joniau, Steven $u Department of Urology, University Hospitals Leuven, Leuven, Belgium
- 700 1_
- $a Van Poppel, Hendrik $u Department of Urology, University Hospitals Leuven, Leuven, Belgium
- 700 1_
- $a de la Taille, Alexandre $u Department of Urology, University Hospital Henri Mondor, AP-HP, UPEC, AP-HP, 51 Avenue du Maréchal de Lattre de Tassigny, 95010, Créteil Cedex, France
- 700 1_
- $a Bensalah, Karim $u Department of Urology, University Hospital of Rennes, Rennes, France
- 700 1_
- $a Bruyère, Franck $u Department of Urology, University Hospital of Tours, Tours, France
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria $u Department of Urology, Weill Cornell Medical College, New York, NY, USA $u Department of Urology, University of Texas Southwestern, Dallas, TX, USA $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan
- 700 1_
- $a Pradere, Benjamin $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. benjaminpradere@gmail.com $u Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France. benjaminpradere@gmail.com
- 773 0_
- $w MED00004739 $t World journal of urology $x 1433-8726 $g Roč. 40, č. 7 (2022), s. 1689-1696
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35596017 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134447 $b ABA008
- 999 __
- $a ok $b bmc $g 1821840 $s 1169178
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 40 $c 7 $d 1689-1696 $e 20220520 $i 1433-8726 $m World journal of urology $n World J Urol $x MED00004739
- LZP __
- $a Pubmed-20220720
